Shares of Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) have been given an average rating of “Moderate Buy” by the six brokerages that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company.
Several brokerages have commented on STVN. Morgan Stanley reissued an “equal weight” rating and issued a $23.00 price target (down from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Wolfe Research initiated coverage on Stevanato Group in a research report on Friday, December 13th. They set an “outperform” rating and a $28.00 target price for the company. Finally, Bank of America raised their price target on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, December 13th.
Get Our Latest Research Report on Stevanato Group
Institutional Investors Weigh In On Stevanato Group
Stevanato Group Stock Down 1.9 %
Shares of NYSE STVN opened at €22.06 ($22.74) on Friday. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The company has a market cap of $6.68 billion, a P/E ratio of 46.94, a P/E/G ratio of 7.76 and a beta of 0.56. Stevanato Group has a 52 week low of €16.56 ($17.07) and a 52 week high of €34.35 ($35.41). The business has a 50-day simple moving average of €21.94 and a two-hundred day simple moving average of €20.53.
Stevanato Group (NYSE:STVN – Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.12) EPS for the quarter, missing analysts’ consensus estimates of €0.13 ($0.13) by (€0.01) (($0.01)). The firm had revenue of €277.90 million during the quarter, compared to the consensus estimate of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. Stevanato Group’s revenue was up 2.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.16 earnings per share. Research analysts anticipate that Stevanato Group will post 0.5 earnings per share for the current fiscal year.
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Stories
- Five stocks we like better than Stevanato Group
- Top Biotech Stocks: Exploring Innovation Opportunities
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.